Recent Updates
Recently added Catalysts
TVTX Positive Sentiment

Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum

Key Takeaway: Travere Therapeutics will present at the Stifel 2026 Virtual Immunology and Inflammation Forum on September 24, 2026. The presentation will be accessible via a live webcast on the company's investor page, with a replay available for 30 days post-event. This engagement underscores Travere's commitment to addressing the needs of the rare disease community.
Price reaction · baseline $64.74 (2026-09-17 close) · hit after-hours · clean, no other TVTX news in the window
day 0 close · peak
-3.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Travere Therapeutics is actively engaging with the rare disease community.
  • The presentation at a prominent forum highlights the company's commitment to innovation.
  • Live webcasts increase accessibility for stakeholders and interested parties.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+24%
120-day peak, hindsight
Typical move
10.2%
average across 11 past catalysts
Lead asset
L-Citrulline
Phase 3 · Sickle Cell Disease

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)-- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will present at the Stifel 2026 Virtual Immunology and Inflammation Forum on Thursday, September 24, 2026, at 10:30 a.m. ET.
Live webcast of the presentation will be accessible on the Investor page of Travere’s website at ir.travere.com/events-and-presentations . Replay will be available for up to 30 days following the event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com .

Frequently Asked Questions

When will Travere Therapeutics present at the forum?

Travere Therapeutics will present on September 24, 2026, at 10:30 a.m. ET.

How can I access the presentation?

The presentation will be available via a live webcast on Travere's investor page.

Will there be a replay of the presentation?

Yes, a replay will be available for up to 30 days after the event.

What is the focus of Travere Therapeutics?

Travere Therapeutics focuses on developing therapies for patients with rare diseases.

Last updated: Sep 17, 2026